Extended adjuvant temozolomide in newly diagnosed glioblastoma: the more, the better?

Neuro Oncol. 2021 Sep 1;23(9):1614-1615. doi: 10.1093/neuonc/noab110.

Authors

Binghao Zhao¹, Wenbin Ma¹

Affiliation

¹ Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Agents, Alkylating / therapeutic use
Dacarbazine / therapeutic use
Glioblastoma* / drug therapy
Humans
Temozolomide / therapeutic use

Substances

Antineoplastic Agents, Alkylating
Dacarbazine
Temozolomide